Merck
  • Home
  • Search Results
  • Reconditioning of an injured lung graft with intrabronchial surfactant instillation in an ex vivo lung perfusion system followed by transplantation.

Reconditioning of an injured lung graft with intrabronchial surfactant instillation in an ex vivo lung perfusion system followed by transplantation.

The Journal of surgical research (2013-05-28)
Ilhan Inci, Sven Hillinger, Stephan Arni, Tevfik Kaplan, Demet Inci, Walter Weder
ABSTRACT

We tested whether an injured lung graft from category-3 donation after cardiac death donor could be reconditioned with an ex vivo lung perfusion (EVLP) system by intrabronchial diluted surfactant lavage before transplantation. In a pig model, cardiac arrest was induced by deconnecting from the ventilator. Left lung injury was done by intrabronchial instillation of 1 mL/kg pepsin + HCl. After retrieval, the heart-lung block was stored at 4°C for 2 h. In the treated group, transplantation was performed after reconditioning with intrabronchial diluted surfactant lavage in EVLP system. During EVLP, surfactant group showed better oxygenation and lower pulmonary vascular resistance. After transplantation, better oxygenation, lower mean pulmonary artery pressure, and lower lung edema were observed in surfactant group. Lower blood IL-1 beta and IL-6 cytokine levels were measured in the surfactant group. In bronchoalveolar lavage, the percentage of neutrophils, IL-1 beta and IL-6 cytokine levels, amount of protein, and neutrophil infiltration in the lung tissue at the end of the experiment were significantly lower in the surfactant group. Our data demonstrate the feasibility of reconditioning and transplantation of an acutely damaged lung graft due to aspiration from a category-3 DCD donor. Implementation of an EVLP system is an efficacious tool to recondition and assess a questionable graft before transplantation.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
盐酸, ACS reagent, 37%
Sigma-Aldrich
盐酸, ACS reagent, 37%
Sigma-Aldrich
氯化氢 溶液, 4.0 M in dioxane
Sigma-Aldrich
胃蛋白酶 来源于猪胃粘膜, powder, ≥250 units/mg solid
Sigma-Aldrich
盐酸, 36.5-38.0%, BioReagent, for molecular biology
Sigma-Aldrich
盐酸 溶液, 1.0 N, BioReagent, suitable for cell culture
Sigma-Aldrich
盐酸, puriss. p.a., ACS reagent, reag. ISO, reag. Ph. Eur., fuming, ≥37%, APHA: ≤10
Sigma-Aldrich
胃蛋白酶 来源于猪胃粘膜, lyophilized powder, ≥3,200 units/mg protein
Sigma-Aldrich
氯化氢 溶液, 2.0 M in diethyl ether
Sigma-Aldrich
盐酸, 37 wt. % in H2O, 99.999% trace metals basis
Sigma-Aldrich
盐酸, puriss., 24.5-26.0%
Supelco
盐酸 溶液, volumetric, 0.1 M HCl (0.1N), endotoxin free
Sigma-Aldrich
胃蛋白酶 来源于猪胃粘膜, powder, ≥400 units/mg protein
Sigma-Aldrich
盐酸, meets analytical specification of Ph. Eur., BP, NF, fuming, 36.5-38%
Sigma-Aldrich
氯化氢, ReagentPlus®, ≥99%
Sigma-Aldrich
盐酸 溶液, ~6 M in H2O, for amino acid analysis
Supelco
氯化氢 - 1-丁醇 溶液, ~3 M in 1-butanol, for GC derivatization, LiChropur
Sigma-Aldrich
盐酸 溶液, 32 wt. % in H2O, FCC
Sigma-Aldrich
氯化氢 溶液, 1.0 M in diethyl ether
Sigma-Aldrich
氯化氢 溶液, 3 M in cyclopentyl methyl ether (CPME)
Supelco
氯化氢 – 乙醇 溶液, ~1.25 M HCl, for GC derivatization, LiChropur
胃蛋白酶, powder, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
胃蛋白酶 来源于猪胃粘膜, powder, slightly beige, ≥500 U/mg
Sigma-Aldrich
胃蛋白酶 来源于猪胃粘膜, powder, slightly beige, 1200-2400 U/mg
Sigma-Aldrich
氯化氢 溶液, 1.0 M in acetic acid
Sigma-Aldrich
胃蛋白酶−琼脂糖 来源于猪胃粘膜, lyophilized powder, ≥30 units/mg dry solid
Sigma-Aldrich
胃蛋白酶 来源于猪胃粘膜, Suitable for manufacturing of diagnostic kits and reagents, lyophilized powder, ≥3200 units/mg protein